Table 1.
Participant flow and data completeness
Characteristics and Results | |
---|---|
Participant characteristics (n = 16) | |
Age, yr | 57.4 (9.7) [37.7–72.1] |
Women, n (%) | 7 (43.8%) |
Ischemic stroke type, n (%) | 12 (75%) |
Years poststroke | 6.5 (4.1) [0.5–16.1] |
Body mass index, kg/m2 | 27.6 (3.7) [21.4–35.5] |
Comfortable gait speed, m/s | 0.72 (0.33) [0.07–1.13] |
%Predicted | 54.2 (25.3) [5.2–91.4] |
Fastest gait speed, m/s | 0.90 (0.41) [0.07–1.37] |
β-Blocker use, n (%) | 3 (18.8%) |
Age-predicted maximal HR,* beat/min | 160 (20) [118–182] |
Resting HR, beat/min | 69 (11) [49–85] |
Baseline GXT results | |
Time to exhaustion, min | 7.9 (3.2) [3.3–12.9] |
V̇o2peak, ml·kg−1·min−1 | 17.2 (3.3) [11.3–22.2] |
%Predicted | 65.8 (13.7) [39.6–87.5] |
V̇o2-VT, ml·kg−1·min−1 | 11.6 (2.5) [7.2–15.0] |
HRpeak, beats/min | 139 (21) [98–174] |
%Predicted | 87.1 (8.6) [75.4–102.9] |
HR-VT, beats/min | 110 (20) [72–153] |
Peak respiratory exchange ratio | 1.07 (0.09) [0.93–1.25] |
Data are presented as means (SD) [range] or n (%). HR, heart rate; GXT, graded exercise testing; V̇o2-VT, V̇o2 at ventilatory threshold; V̇o2peak. peak oxygen consumption rate; HRpeak, peak heart rate; HR-VT, heart rate at ventilatory threshold.
Adjusted for β-blocker use (see materials and methods).